As spending on pharmaceuticals continues to accelerate in Japan, the government is exploring ways to control the surging costs of drugs essential for maintaining the health of its aging population.
The Ministry of Finance plans to call for cuts to the standard prices of drugs and for other cost-controlling measures to Japan's national health insurance plans in the next fiscal year. And beginning in fiscal 2021, Japan plans to review drug prices annually, instead of every two years, as it currently does.
But developing drugs requires massive investments. Critics say cutting drug prices further is likely to adversely impact the development of new treatments. Meanwhile, drugs in high demand, including cutting edge treatments for hepatitis C and new anti-cancer drugs, will continue to drive escalating healthcare spending
About Pacific Bridge Medical
Pacific Bridge Medical (PBM) was founded in 1988 to help international medical companies solve their most complex problems while doing business in Asia. Since then, PBM has assisted hundreds of healthcare companies with business development and regulatory issues in Asia. We provide our services to all types of medical firms, including medical device, IVD, pharmaceutical, and API.
------------------------------
Ames Gross
President
Pacific Bridge Medical
Bethesda, MD
www.pacificbridgemedical.comcontact@pacificbridgemedical.com------------------------------